# reload+after+2024-01-23 12:38:25.989682
address1§21 Plumbers Row
city§London
zip§E1 1EQ
country§United Kingdom
phone§44 20 7756 1300
website§https://www.hvivo.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
fullTimeEmployees§210
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Yamin Mohammed Khan Ph.D.', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 591540, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen  Pinkerton', 'age': 58, 'title': 'CFO & Executive Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 185325, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Catchpole', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Maurice N. Treacy Ph.D.', 'title': 'Chief Commercial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Teja  Marathe-Sarvadikar', 'title': 'Head of QA', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
exDividendDate§1683158400
payoutRatio§0.0
beta§1.007
priceToSalesTrailing12Months§2.9977696
currency§GBp
forwardEps§1.18
exchange§LSE
quoteType§EQUITY
shortName§HVIVO PLC ORD 0.1P
longName§hVIVO plc
firstTradeDateEpochUtc§1355472000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§26ec2205-4ed6-3ad8-997b-a4e935c9bc06
targetHighPrice§35.0
targetLowPrice§27.0
targetMeanPrice§29.67
targetMedianPrice§29.0
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§1.412
earningsGrowth§13.573
grossMargins§0.19859
ebitdaMargins§0.16499001
trailingPegRatio§None
